| Non neoplasia | Hepatocarcinoma | Fold Change | p value* |
---|---|---|---|---|
NAIP (BIRC1) | 1,24 (0,01–2,6) | 0,82 (0,0004–3,6) | 0,67 |  |
c-IAP1 (BIRC2) | 2,13 (0.06–5.5) | 1,94 (0.01–5.8) | 0,91 |  |
c-IAP2 (BIRC3) | 1,23 (0.1–6.1) | 1,21 (0.04–5.9) | 0,99 |  |
XIAP (BIRC4) | 0,86 (0.3–2.5) | 0,99 (0.06–2.2) | 1,15 |  |
Survivin (BIRC5) | 0,03 (0.03–0.1) | 0,20 (0.1–1.6) | 6,86 | 1·10–6 |
Bruce (BIRC6) | 1,36 (0.06–5.9) | 1,36 (0.02–3.3) | 1,00 |  |
Livin/ML-IAP (BIRC7) | 0,13 (0.01–1.5) | 0,31 (0.01–3.6) | 2,33 | 6·10–3 |
XAF1 (BIRC4BP) | 0,69 (0.1–2.4) | 0,61 (0.07–3.9) | 0,88 |  |
Smac/DIABLO | 1,03 (0.4–2.1) | 1,13 (0.4–3.6) | 1,10 |  |
Ratio XIAP/XAF1 | 2,29 (0.3–12.9) | 6,90 (0.2–47.0) | 3,02 | 3·10–4 |
Ratio XIAP/Smac/DIABLO | 0,92 (0.04–2.0) | 1,00 (0.01–4.2) | 1,09 |  |